Accueil   Diary - News   All news Diabeloop obtains CE marking and launches new round of funding

Diabeloop obtains CE marking and launches new round of funding

The disruptive innovation for autonomous management of T1D


Pari, November 7: Diabeloop announced today it has received the CE marking for the DBLG1™, its innovative technological solution to radically improve quality of life for T1D patients through better blood sugar management. This news represents an important step towards the commercial release of the product.


Developed both for and with the patients, together with a team of engineers and medical researchers, the DBLG1™ is at the heart of an hybrid closed-loop system integrating powerful algorithms into a secured terminal. Linked to a continuous blood glucose monitoring system and a insulin patch pump, it can predict glucose levels and command the insulin pump at an optimal rate. This self-learning and highly customizable system can reproduce the insulin-dispensing functions of a pancreas and adapt to the patient’s physiology and lifestyle.


Read the press release